Secretory acid sphingomyelinase activity is elevated in White but not Black individuals with colorectal neoplasia

Clicks: 11
ID: 337593
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #62 of 67 articles by views in journal of carcinogenesis

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Changes in lipid metabolism have been associated with the development of colorectal cancer (CRC), and they may serve as diagnostic markers to identify patients who have developed colorectal neoplasia. This study aimed to identify such biomarkers using untargeted lipidomics. Lipidomics were performed in serum from a racially diverse series of CRC cases and controls from Chicago and Tucson. In addition, enzymatic activity of secretory acid sphingomyelinase (aSMase; S-SMase) was measured in samples from the Tucson CRC series, and two series of adenoma patients. Untargeted lipidomics in the Chicago CRC series revealed significant alterations in sphingolipids. Targeted lipidomics revealed a robust signature of five sphingomyelins (SMs) that were significantly decreased in Chicago CRC patients compared to controls and were validated in the Tucson series. S-SMase activity, which degrades serum SMs, was elevated in CRC cases (0.13 ± 0.10 Cer/SM UACC CRC cases vs. 0.05 ± 0.04 Cer/SM controls; p<0.0001). In mostly white adenoma patients from Tucson, serum S-SMase activity could predict the presence of colorectal neoplasia (0.13 ± 0.07 Cer/SM in UACC adenoma cases vs. 0.03 ± 0.02 Cer/SM in controls; p<0.0001). However, S-SMase activity was not significantly different in Black adenoma patients from Chicago compared to controls. Together, these studies demonstrate for the first time the potential for S-SMase activity to serve as a biomarker for colorectal neoplasia in specific populations.
Reference Key
openalex_W7224083326 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal journal of carcinogenesis
Year 2026
DOI
10.1093/carcin/bgag079
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.